Stimulation of activated HSCs by TGF-β1 is believed to be the key fibrogenic response in liver fibrosis [22]; strategies aimed at disrupting TGF-β1 expression are a key approach in the prevention and treatment of liver fibrosis [23]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.